Vident Investment Advisory, LLC Zymeworks Inc. Transaction History

Vident Investment Advisory, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$15.19 - $29.33 $589,128 - $1.14 Million	-38,784 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$27.35 - $37.28 $75,759 - $103,265	-2,770 Reduced 6.67%	38,784 $1.13 Million
Q2 2021 Aug 13, 2021	BUY	$26.5 - $38.23 $275,229 - $397,056	10,386 Added 33.32%	41,554 $1.44 Million
Q4 2020 Feb 08, 2021	SELL	$39.12 - $54.99 $203,619 - $286,222	-5,205 Reduced 14.31%	31,168 $1.47 Million
Q3 2020 Nov 12, 2020	SELL	$29.21 - $46.58 $79,538 - $126,837	-2,723 Reduced 6.96%	36,373 $1.69 Million
Q2 2020 Jul 17, 2020	BUY	$33.67 - $40.0 $175,521 - $208,520	5,213 Added 15.39%	39,096 $1.41 Million
Q1 2020 May 12, 2020	SELL	$24.28 - $49.8 $58,441 - $119,868	-2,407 Reduced 6.63%	33,883 $1.2 Million
Q4 2019 Feb 11, 2020	SELL	$24.84 - $45.46 $798,456 - $1.46 Million	-32,144 Reduced 46.97%	36,290 $1.65 Million
Q3 2019 Nov 13, 2019	SELL	$22.78 - $29.08 $59,045 - $75,375	-2,592 Reduced 3.65%	68,434 $1.7 Million
Q2 2019 Aug 12, 2019	BUY	$15.0 - $22.49 $1.07 Million - $1.6 Million	71,026 New	71,026 $1.56 Million
Q4 2018 Feb 14, 2019	SELL	$10.95 - $15.44 $1.56 Million - $2.2 Million	-142,306 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$12.21 - $16.61 $115,811 - $157,545	-9,485 Reduced 6.25%	142,306 $2.23 Million
Q2 2018 Aug 14, 2018	BUY	$11.13 - $21.86 $1.69 Million - $3.32 Million	151,791 New	151,791 $2.24 Million

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $806M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.